Orient Pharma Co., Ltd. (TPEX:4166)

Orient Pharma Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	84.5	83.32	76.43	130.92	49.58
Short-Term Investments	24.8	29.8	20.8	20.8	140.8
Cash & Short-Term Investments	109.3	113.12	97.23	151.72	190.38
Cash Growth	-3.38%	16.34%	-35.92%	-20.30%	227.64%
Accounts Receivable	278.18	179.31	69.39	63.09	78.2
Other Receivables	10.36	8.16	12.91	16.82	2.35
Receivables	288.54	187.47	82.3	79.9	80.56
Inventory	279.56	233.97	194.18	156.88	138.64
Prepaid Expenses	44.12	58	39.18	30.91	14.75
Other Current Assets	6.91	29.7	10.24	19.89	9.5
Total Current Assets	728.43	622.25	423.12	439.31	433.83
Property, Plant & Equipment	891.83	944.96	903.28	769.71	792.66
Long-Term Investments	13.65	1.88	3.05	1.75	3.13
Other Intangible Assets	471.83	532.66	11.9	13.75	25.36
Long-Term Deferred Tax Assets	397.98	451.46	452.04	439.2	428.01
Other Long-Term Assets	16.87	9.47	54.18	100.1	60.82
Total Assets	2,521	2,563	1,848	1,764	1,744
Accounts Payable	36.14	55.57	61.97	19.6	28.63
Accrued Expenses	-	62.04	53.5	59.07	115.75
Short-Term Debt	250	314.5	68.5	161.5	32
Current Portion of Long-Term Debt	40	60.71	24.08	23.83	23.47
Current Portion of Leases	18.44	17.95	14.92	8.22	3.35
Current Unearned Revenue	64.51	22.01	64.87	78.07	44.73
Other Current Liabilities	78.17	30.56	63.22	69.17	2.33
Total Current Liabilities	487.25	563.35	351.06	419.46	250.25
Long-Term Debt	42.1	112.06	178.79	111.8	152.62
Long-Term Leases	195.95	211.67	221.86	109.67	112.26
Long-Term Deferred Tax Liabilities	1.84	-	-	0.13	0.01
Other Long-Term Liabilities	-	-	-	-	1.6
Total Liabilities	733	892.18	757.65	647.9	526.41
Common Stock	2,230	2,230	1,870	1,870	1,870
Additional Paid-In Capital	1,130	1,130	932.15	932.15	932.23
Retained Earnings	-1,579	-1,686	-1,709	-1,682	-1,581
Comprehensive Income & Other	6.05	-3.83	-2.89	-4.6	-3.63
Shareholders' Equity	1,788	1,670	1,090	1,116	1,217
Total Liabilities & Equity	2,521	2,563	1,848	1,764	1,744
Total Debt	546.49	716.9	508.15	415.01	323.7
Net Cash (Debt)	-437.19	-603.78	-410.92	-263.29	-133.32
Net Cash Per Share	-1.95	-2.71	-2.20	-1.41	-0.79
Filing Date Shares Outstanding	224.36	223.04	187	187	187.01
Total Common Shares Outstanding	224.36	223.04	187	187	187.01
Working Capital	241.18	58.9	72.07	19.86	183.58
Book Value Per Share	7.97	7.49	5.83	5.97	6.51
Tangible Book Value	1,316	1,138	1,078	1,102	1,192
Tangible Book Value Per Share	5.86	5.10	5.76	5.89	6.37
Buildings	-	786.78	744.9	682.91	682.83
Machinery	-	430.96	367.95	361.11	340.78

Source: S&P Global Market Intelligence. Standard template. Financial Sources.